Internationally known for clinical excellence and cutting-edge research, we provide promising treatment options for adult and pediatric patients. Our program was one of the nation's first, and has evolved into one of the most active and advanced in the world.Yale is internationally recognized as a leader in innovative treatment for medically intractable and new onset epilepsy. We treat patients in outpatient settings, at a six-bed adult epilepsy monitoring unit, a two-bed pediatric epilepsy monitoring unit, and a technologically advanced operating suite. We are also equipped with state-of-the-art technology for continuous brain and video monitoring of seizures in children and infants. We evaluate patients in phases to precisely determine concordance of electrophysiology, cognitive testing, history, as well as physical and neurological examination with advanced imaging, using MRI, SPECT, and PET techniques. Doctors treat each surgical patient as an individual, determining which procedure or combination of procedures is appropriate.

Yale Program in Addiction Medicine physicians and advanced practice providers prevent, diagnose, and treat substance use disorders and related harms. Our program, founded on over 30 years of pioneering research designed to integrate addiction treatment into general medical settings, is internationally recognized for leadership in the field and innovative approaches to care. Our clinicians are experienced in treating opioid, alcohol, tobacco, and other substance use disorders and in providing medications and behavioral therapy for substance use treatment. Our clinicians have training in a wide range of areas in medicine including internal medicine, primary care, emergency medicine, pediatrics, infectious diseases, psychiatry, pulmonary and critical care medicine. They are experienced in providing treatment for substance use alongside pregnancy and care for other co-occurring conditions such as pain, Hepatitis C, HIV, bacterial infections, and mental health diagnoses. Yale Program in Addiction Medicine clinicians see patients in community health centers, primary care clinics, infectious disease clinics, the emergency department, and in the hospital. We emphasize a patient-centered approach to care and will work with patients and their families to identify a treatment plan that best supports the patient’s needs and goals. Our clinicians meet patients where they are—whether they are new to treatment, returning to treatment, or exploring ways to reduce risk associated with substance use. Our dedicated clinicians are experienced in treating the full spectrum of substance use from intermittent use to severe substance use disorder. We use evidence-based treatment strategies to care for patients throughout the often relapsing-remitting nature of the disease of addiction and are supported by a large community of experts in the field working to develop and make available innovative, effective treatment options. In collaboration with our many community-based and institutional partners, we offer a robust network of care options to ensure appropriate support for our patients at every stage of treatment. Yale School of Medicine is a teaching institution. As such, patient care teams may include physician fellows, residents, advanced practice trainees, and or medical students being trained by our program in addiction medicine. The Yale Program in Addiction Medicine houses a robust research portfolio focused on advancing innovative treatments and improving the quality and efficacy of care for our patients. We are internationally recognized for our scholarly contributions to the field, particularly with respect to implementation and evaluation of medications for substance use treatment in primary care clinics, infectious disease clinics, the emergency department, and in the hospital, as well as comprehensive training and education of the next generation of addiction medicine providers. Our faculty and collaborators form an interdisciplinary team representing intern

Quitting tobacco is difficult. In the tobacco treatment program at Smilow Cancer Hospital, we offer quitting strategies that combine counseling and drug treatment to help patients reduce nicotine withdrawal symptoms, cope with cravings, and break the cycle of tobacco use. Our program includes a multidisciplinary team of advanced nurse practitioners, psychologists, physicians, and research staff. We tailor treatment to each patient’s situation and tobacco use history. It is critical that cancer patients quit smoking after initial diagnosis. Quitting has been shown to improve response to cancer treatments such as therapeutic radiology, chemotherapy, and surgery; decrease the likelihood of second malignancies; and increase rates of survival. In general, the immediate health benefits of stopping tobacco use include: Increased blood oxygen levels Decreased heart rate, blood pressure, chance of heart attack The long-term benefits include: Increased lung health, fertility, and health of skin, teeth, and gums Decreased risk for lung and other kinds of cancer, as well as for heart disease The Tobacco Treatment Program operates on the principles of the U.S. Public Health Service Clinical Practice Guidelines. Our treatment strategies may include safe, effective FDA-approved medications such as nicotine replacement (patch, gum, lozenge, inhaler or nasal spray), bupropion (Zyban), and varenicline (Chantix). In addition, we provide individual counseling to help patients learn other ways to manage stress and improve mood, as well as develop new and healthy daily routines. Tobacco products are rapidly changing with the advent of new technology. E-cigarettes heat a liquid with nicotine and other chemicals in it. They are likely less harmful than cigarettes, but they are not harmless. The inhaled vapor contains toxic chemicals including cancer-causing agents and tiny particles that can enter the lungs. E-cigarettes also contain nicotine, which is what makes tobacco addictive. Any plans to use e-cigarettes to quit tobacco should also include a plan for weaning from e-cigarettes. Our program provides treatment for non-English speakers and includes Telehealth video visits. You can also get text support through SmokefreeTXT (Text YALE to 47848). We focus on helping our patients stop tobacco use–on their timeline–and gain specific skills to prevent or handle “slips” and maintain their long-term goals.